Hide Board Information

Show Board Information

BioElectronics Corporation BIEL

Board Mod: BielyMonster

Asst Mods: iwantutowantBIEL Chanel5

Last Post: 09/06/2025 7:12:46 PM

Board Marks: 111

Posts Today: 0

Board Views Today: 649

BioElectronics Corporation (BIEL)

Company Website: http://www.bielcorp.com/

BioElectronics Corporation (OTCMRKTS: BIEL) Stock Message Board

1. BIEL Company Profile

    

2. BIEL Time & Sales

    

3. BIEL Recent News

    

4. BIEL Filings

    

5. BIEL Financials

    

6. BIEL Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7501	Must Watch RecoveryRX Video, Amazing!! (4)	BielyMonster	08/25/2024 8:56:51 PM
7668	PR out, BioElectronics Corporation's Chairman	swordfish	10/16/2024 9:52:05 AM
7853	https://www.actipatchtw.com/general-1?pgid=lw7ink (1)	Chanel5	12/06/2024 11:51:45 AM
7954	ActiPatch Taiwan distributor, Aphrodite (2)	swordfish	01/21/2025 10:22:15 AM
2	BIEL closed the week up 460% on over a billion	$maker	02/22/2014 11:47:36 AM
1	BIEL News BioElectronics Continues to	lucyinthesky	10/02/2012 9:02:14 AM

Newer

Recent Articles

• Significant Global Benefits of Ivonescimab in Cancer Treatment
• Surf Dog Surf-a-Thon Celebrates 20th Anniversary with Fun
• Political Tensions Rise as Trump Points to Investment Risks
• Microsoft Responds to Azure Latency Due to Undersea Cable Issue
• Insights from the Global South Media and Think Tank Forum
• Zidesamtinib Data Highlights Significant Advances in NSCLC Treatment
• Transforming Your Home: The Power of Staging and Decluttering
• Federal Control Discussions Over 9/11 Memorial Continue Amid Criticism
• Understanding Slip and Fall Liability: A Comprehensive Guide
• Understanding Capacity Management for Better Workplace Health
• Trump's Upcoming APEC Summit Visit: Trade Talks and Diplomacy
• Exploring the Latest Trends in US Casino Games for 2025
• Groundbreaking Dual Therapy Breathes New Life into Lung Cancer Treatment
• Revolutionizing Lung Cancer Treatment: RYBREVANT and LAZCLUZE Effectiveness
• Tesla's Investor Push for Political Neutrality in Company Strategy
• Geoffrey Hinton Warns: AI's Impact on Jobs Reflects Capitalism
• GAC Collaborates with SKAI ISYOURGOD on New SUV Campaign
• Max Stock Ltd. Receives Resignation News from Deputy CEO
• Tesla's Bold Leap: AI5 Chip Review Success and Market Strategy
• Artists for Peace and Justice Gala: A Night of Giving
• Trump Administration Moves Forward with $30 Billion IPO Plans
• Military Movements and Drug Trafficking: U.S. Response Explained
• HKC Group's Three Brand Launch at IFA 2025: A Revolution
• Discover How Midea Transforms Kitchens with Style and Grace
• Protests Emerge Against Military Actions in Washington D.C.
• Tariff Dilemma: Exporters Redirect Focus to China Amid Price Hikes
• Celebrating Excellence: Highlights from the Sunshine State Awards
• AIR RACE X: The Future of High-Speed Aerial Excitement
• Biohaven Ltd. Investors Take Action Against Securities Fraud
• Introducing 247Tasker: Revolutionizing Freelancing Globally
• Urgent Investor Alert: Centene Corporation Class Action Insights
• Dimassi's Mediterranean Buffet Expands to New Location in Texas
• COLMO's EVOLUTION 2.0 Series Transforms Luxury Home Living
• COLMO EVOLUTION 2.0: A Gold Standard in Home Innovation
• Empowering Teenagers Through Success-in-You Program Launch
• Air Canada and CUPE Enter Mediation Amid Wage Negotiations
• RugOne Launches Innovative Rugged Smartphone at IFA 2025
• GlocalMe Unveils Innovative Solutions at Major Tech Expo
• Investors Have a Unique Opportunity for Recovery with CTO Realty
• Picasso Print DTF Increases Production by 130% with AI Technology
• Rosen Law Firm Investigates Disney for Children's Privacy Concerns
• Understanding Unclaimed Lottery Winnings: Powerball Insights
• TCL Achieves Milestone in Mini LED Market Share Growth
• GlocalMe Unveils Innovative Connectivity Solutions at IFA 2025
• John Monsky's Impactful Multisensory Performance for Kids
• Investors Urged to Lead Class Action Against Altimmune, Inc.
• Critical Guidance for Fiserv, Inc. Investors Facing Losses
• Encaleret Demonstrates Exciting Results for Calcium Normalization
• Federal Court Upholds Immigration Protections for TPS Holders
• Harnessing Executive Function Coaching for Long-Term Success